Related references
Note: Only part of the references are listed.Regulatory functions of the Mediator kinases CDK8 and CDK19
Charli B. Fant et al.
TRANSCRIPTION-AUSTIN (2019)
Cyclin-Dependent Kinase 8: A New Hope in Targeted Cancer Therapy? Miniperspective
Stephen Philip et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Jianfang Liu et al.
CELL (2018)
Mediator kinase CDK8/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer
Anne Serrao et al.
ONCOGENE (2018)
CDK8/19 inhibition induces premature G1/S transition and ATR-dependent cell death in prostate cancer cells
Akito Nakamura et al.
Oncotarget (2018)
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Adam Nagy et al.
SCIENTIFIC REPORTS (2018)
CDK8 Selectively Promotes the Growth of Colon Cancer Metastases in the Liver by Regulating Gene Expression of TIMP3 and Matrix Metalloproteinases
Jiaxin Liang et al.
CANCER RESEARCH (2018)
Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer
Johannes Braegelmann et al.
CLINICAL CANCER RESEARCH (2017)
CDK8/19 Mediator kinases potentiate induction of transcription by NFκB
Mengqian Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer
Martina S. J. McDermott et al.
ONCOTARGET (2017)
SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains
Tomasz Rzymski et al.
ONCOTARGET (2017)
Defining a Cancer Dependency Map
Aviad Tsherniak et al.
CELL (2017)
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Himisha Beltran et al.
NATURE MEDICINE (2016)
Treating cancer with selective CDK4/6 inhibitors
Ben O'Leary et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway
Wei Xu et al.
CANCER LETTERS (2015)
Expression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast Cancer
Eugenia V. Broude et al.
CURRENT CANCER DRUG TARGETS (2015)
MED12 and uterine smooth muscle oncogenesis: State of the art and perspectives
Sabrina Croce et al.
EUROPEAN JOURNAL OF CANCER (2015)
Mediator kinase inhibition further activates super-enhancer-associated genes in AML
Henry E. Pelish et al.
NATURE (2015)
An ecosystem of cancer cell line factories to support a cancer dependency map
Jesse S. Boehm et al.
NATURE REVIEWS GENETICS (2015)
Skp2-MacroH2A1-CDK8 axis orchestrates G2/M transition and tumorigenesis
Dazhi Xu et al.
NATURE COMMUNICATIONS (2015)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
CDK8 Maintains Tumor Dedifferentiation and Embryonic Stem Cell Pluripotency
Adam S. Adler et al.
CANCER RESEARCH (2012)
MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
Sidong Huang et al.
CELL (2012)
Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities
Donald C. Porter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
CDK8 expression in 470 colorectal cancers in relation to β-catenin activation, other molecular alterations and patient survival
Ron Firestein et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
The histone variant macroH2A suppresses melanoma progression through regulation of CDK8
Avnish Kapoor et al.
NATURE (2010)
CDK8 A positive regulator of transcription
Matthew D. Galbraith et al.
TRANSCRIPTION-AUSTIN (2010)
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro
Richard S. Finn et al.
BREAST CANCER RESEARCH (2009)
CDK8 is a colorectal cancer oncogene that regulates β-catenin activity
Ron Firestein et al.
NATURE (2008)
Share Paper
